JENNIFER LIVINGSTON: Open Payments
NPI 1679513907 · LIVINGSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 26 payments from 9 companies in 2025. Trend: 2023 $380 · 2024 $436 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 5 | $130 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Exact Sciences Corporation | 3 | $54 |
| Astellas Pharma US Inc | 2 | $47 |
| Dexcom, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: YUPELRI, TRELEGY ELLIPTA, XIFAXAN, AIRSUPRA, Veozah, Dexcom G6 Transmitter, Cologuard Collection Kit, BREZTRI.
Industry payments across TX — which companies pay providers there.
